Identifying drug targets in tissues and whole blood with thermal-shift profiling
Jessica Perrin(GlaxoSmithKline (Germany)), Giovanna Bergamini(Heidelberg Engineering (Germany)), Daniel C. Sévin(GlaxoSmithKline (Germany)), Wolfgang Huber(European Molecular Biology Laboratory), Katrin Strohmer(GlaxoSmithKline (Germany)), Maria Faelth-Savitski(GlaxoSmithKline (Germany)), Thilo Werner(GlaxoSmithKline (Germany)), Mathias Kalxdorf(German Cancer Research Center), Bianca Heller(GlaxoSmithKline (Germany)), Jana Krause(GlaxoSmithKline (Germany)), H. Christian Eberl(GlaxoSmithKline (Germany)), Anna Rutkowska(Opole University of Technology), Douglas W. Thomson(GlaxoSmithKline (Germany)), Marcus Bantscheff(Roche (Switzerland)), Isabelle Becher, Christina Rau(GlaxoSmithKline (Germany)), Eugenia Stonehouse(GlaxoSmithKline (Germany)), Daniel Poeckel, Johanna Vappiani(Diabetesinstitut Heidelberg), Nils Kurzawa(Institute for Research in Biomedicine), Mikhail M. Savitski(European Molecular Biology Laboratory), Holger Franken(GlaxoSmithKline (Germany)), Dorothee Childs(European Molecular Biology Laboratory)
Cited by 195
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Quantitative mass spectrometry in proteomics: a critical review
|Analytical and Bioanalytical Chemistry|2007|1.7k
Detecting differential usage of exons from RNA-seq data
|Genome Research|2012|1.6k